Crossmark

The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications

Crossref DOI link: https://doi.org/10.1016/j.reumae.2020.10.005

Published Print: 2022-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Emad, Yasser

Ragab, Yasser

Hammam, Nevin

El-Shaarawy, Nashwa

Fawzi, Magdy

Amer, Arwa

El-Makhzangy, Hesham

Ismail, Ahmed

Ibrahim, Ossama

Hassan, Yosra

Kamal, Ahmed

Rasker, Johannes J.
License Information

Text and Data Mining valid from 2022-02-01
More Information

This article is maintained by: Elsevier

Article Title: The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2020.10.005

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below